Dawaa Reference

infectious

Hand-Foot-and-Mouth Disease

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

WHO Guide on Hand, Foot and Mouth Disease 2011 · Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560) · StatPearls: Ibuprofen (NCBI Bookshelf NBK542299)

Verified against5 documents
  • WHO Guide on Hand, Foot and Mouth Disease 2011
  • Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560)
  • Hand, Foot, and Mouth Disease - disease-level clinical article (hand-foot-and-mouth-clinical.txt)
  • MSF Essential Drugs 2024 (ibuprofen oral monograph)
  • MSF Essential Drugs 2024 - paracetamol (oral)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (3)

  • HFMD often starts with a mild fever, poor appetite, and general malaise [fever · malaise · poor appetite]
  • Mouth or throat pain from the oral lesions is usually the first symptom noticed [sore throat]
  • The skin lesions are 2 to 6 mm across, are not itchy, are usually painless, and heal without scarring over about ten days [skin lesions]

Signs — what you find (2)

  • Vesicles have a thin rim of redness around them and break down into shallow ulcers with a grey-yellow base and red edge [blisters · mouth ulcers · redness · vesicles]
  • The rash involves the hands, feet, buttocks, legs, and forearms, while mouth lesions usually affect the cheeks and tongue and sometimes the soft palate [rash]

Tests (3)

  • HFMD is diagnosed clinically in most cases without lab testing
  • A vesicle scraping under light microscopy can distinguish HFMD from chickenpox or herpes simplex
  • PCR testing of a swab from a lesion can confirm coxsackievirus or enterovirus infection

If not this — what else fits (4)

  • Monkeypox can be clinically difficult to distinguish from HFMD during an outbreak
  • Herpangina and herpes simplex are also on the differential
  • Kawasaki disease is on the differential for HFMD
  • Varicella zoster infection (chickenpox) is on the differential

SourceStatPearls "Hand, Foot, and Mouth Disease" - disease-level clinical article

Presentation findings are traced to the source above.

1

PARACETAMOL

1st line

Strength120 mg

Formoral.liquid

Adult dose and duration

1 g 3 or 4 times daily (max. 4 g daily) x 5-7 days

Paediatric dose

10-15 mg/kg/dose [child max 500 mg]

(Child 1 month and over: 15 mg/kg 3 or 4 times daily (max. 60 mg/kg daily). Child under 1 month: 10 mg/kg 3 or 4 times daily (max. 40 mg/kg daily).)

Dose by weight
3kg30-45 mg/dose
4kg40-60 mg/dose
5kg50-75 mg/dose
6kg60-90 mg/dose
7kg70-105 mg/dose
8kg80-120 mg/dose
9kg90-135 mg/dose
10kg100-150 mg/dose
11kg110-165 mg/dose
12kg120-180 mg/dose
13kg130-195 mg/dose
14kg140-210 mg/dose
15kg150-225 mg/dose
16kg160-240 mg/dose
17kg170-255 mg/dose
18kg180-270 mg/dose
19kg190-285 mg/dose
20kg200-300 mg/dose
21kg210-315 mg/dose
22kg220-330 mg/dose
23kg230-345 mg/dose
24kg240-360 mg/dose
25kg250-375 mg/dose
26kg260-390 mg/dose
27kg270-405 mg/dose
28kg280-420 mg/dose
29kg290-435 mg/dose
30kg300-450 mg/dose
31kg310-465 mg/dose
32kg320-480 mg/dose
33kg330-495 mg/dose
34kg340-500 mg/dose (upper capped)
35kg350-500 mg/dose (upper capped)
36kg360-500 mg/dose (upper capped)
37kg370-500 mg/dose (upper capped)
38kg380-500 mg/dose (upper capped)
39kg390-500 mg/dose (upper capped)
40kg400-500 mg/dose (upper capped)
41kg410-500 mg/dose (upper capped)
42kg420-500 mg/dose (upper capped)
43kg430-500 mg/dose (upper capped)
44kg440-500 mg/dose (upper capped)
45kg450-500 mg/dose (upper capped)
46kg460-500 mg/dose (upper capped)
47kg470-500 mg/dose (upper capped)
48kg480-500 mg/dose (upper capped)
49kg490-500 mg/dose (upper capped)
50kg500 mg/dose (capped)
Dose source

MSF Essential Drugs 2024 - paracetamol (oral)

Why

Analgesic and antipyretic used for symptomatic relief of fever, sore throat, and malaise in hand-foot-and-mouth disease, a self-limiting viral illness with no antiviral treatment and managed supportively.

Cautions
  • Ensure soft diet and fluid intake to prevent dehydration.
  • Antibiotics are ineffective and contraindicated.
  • Watch for neurological complications: myoclonic jerks, lethargy, or ataxia (EV71 risk).
  • 500 mg is the per-dose ceiling used here for a child. 1000 mg is the adult dose and does not belong in a weight calculation - the daily 60 mg/kg limit is the one that binds first in any case.
Egyptian brands
Egyptian brandManufacturerIndicative price
CETAMOL 120MG/5ML PEDIATRIC SYRUP 120 MLMEMPHIS8.50 EGP
PARAGESIC BABY 120MG/5ML 120ML SUSP.AMRIYA36.00 EGP
PARAMOL 120MG/5ML SYRUP 125MLMISR36.00 EGP
FEBRIMOL ORAL DROPS 20 ML? strength differs? different route - not oral liquidPHARCO4.00 EGP
THERA-LO 3.2G/100ML ORAL SUSP. 100 ML? strength differs? different route - not oral liquidPHAROPHARMA5.00 EGP
2

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line
Dose source

Hand, Foot, and Mouth Disease - disease-level clinical article (hand-foot-and-mouth-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions
  • RED FLAG - The risk factors for severe disease and mortality are lethargy, seizures, dyspnea, and coma.
3

IBUPROFEN

2nd line

Strength100 mg

Formoral.liquid

Adult dose and duration

400 mg 3 times daily after food x 5-7 days

Paediatric dose

5-10 mg/kg/dose [child max 400 mg]

(Every 6-8 hours after food;. Child over 3 months: 5 to 10 mg/kg 3 to 4 times daily, maximum 30 mg/kg daily. The suspension's own label caps pain-and-fever use lower still, at 20 mg/kg/day. Never exceed 400 mg in a single dose.)

Dose by weight
3kg15-30 mg/dose
4kg20-40 mg/dose
5kg25-50 mg/dose
6kg30-60 mg/dose
7kg35-70 mg/dose
8kg40-80 mg/dose
9kg45-90 mg/dose
10kg50-100 mg/dose
11kg55-110 mg/dose
12kg60-120 mg/dose
13kg65-130 mg/dose
14kg70-140 mg/dose
15kg75-150 mg/dose
16kg80-160 mg/dose
17kg85-170 mg/dose
18kg90-180 mg/dose
19kg95-190 mg/dose
20kg100-200 mg/dose
21kg105-210 mg/dose
22kg110-220 mg/dose
23kg115-230 mg/dose
24kg120-240 mg/dose
25kg125-250 mg/dose
26kg130-260 mg/dose
27kg135-270 mg/dose
28kg140-280 mg/dose
29kg145-290 mg/dose
30kg150-300 mg/dose
31kg155-310 mg/dose
32kg160-320 mg/dose
33kg165-330 mg/dose
34kg170-340 mg/dose
35kg175-350 mg/dose
36kg180-360 mg/dose
37kg185-370 mg/dose
38kg190-380 mg/dose
39kg195-390 mg/dose
40kg200-400 mg/dose
41kg205-400 mg/dose (upper capped)
42kg210-400 mg/dose (upper capped)
43kg215-400 mg/dose (upper capped)
44kg220-400 mg/dose (upper capped)
45kg225-400 mg/dose (upper capped)
46kg230-400 mg/dose (upper capped)
47kg235-400 mg/dose (upper capped)
48kg240-400 mg/dose (upper capped)
49kg245-400 mg/dose (upper capped)
50kg250-400 mg/dose (upper capped)
Dose source

Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560) for the adult dose: "The recommended dose is 200 mg-400 mg (10-20 ml), up to three times a day as required... do not take more than 1200 mg (60 ml) in any 24 hour period". That label's paediatric section gives weight bands and a 20 mg/kg/day pain-and-fever ceiling but states no mg/kg per dose, so the paediatric 5 to 10 mg/kg per dose is from MSF Essential Drugs 2024 (ibuprofen oral monograph): "Child over 3 months: 5 to 10 mg/kg 3 to 4 times daily (max. 30 mg/kg daily)".

Why

NSAID alternative for pain relief, particularly useful for painful oral ulcers that limit fluid intake; avoided in severe asthma or dehydration.

Cautions
  • Reduces severe oral ulcer pain enabling fluid intake.
  • Avoid in severe asthma or dehydration.
  • Maintain hand hygiene to prevent household transmission.
  • The 400 mg per-dose ceiling comes from the reference literature, not from the suspension label - that label's largest paediatric single dose is 200 mg. Below about 40 kg the weight calculation binds first and the ceiling never comes into it.
Egyptian brands
Egyptian brandManufacturerIndicative price
NOVA-PROFEN 100MG/5ML ORAL SUSP. 100MLSANOFI2.25 EGP
IBUPROFEN 100MG/5ML SUSP. 120 MLSEDICO5.00 EGP
MARCOFEN 100MG/5ML SUSP. 120MLGLAXO SMITHKLINE5.85 EGP
MAFO 100MG/5ML SYRUP 100 MLEIPICO25.00 EGP
IBUCALMIN 100MG/5ML SYRUP 120 MLMASH PREMIERE28.00 EGP
JUSPOLED 100MG/5ML SYRUP 120 MLEGPI > JASPER FOR PHARMACEUTICAL INDUSTRIES31.00 EGP
MEGAFEN-N 100MG/5ML SUSP. 120 MLRAMEDA35.00 EGP
BRUFEN 100MG/5ML SYRUP 150MLKAHIRA > ABBOTT LABORATORIES44.00 EGP
BRUFEMOL-N SUSP. 60 ML? strength differs? different route - not oral liquidARAB DRUG COMPANY (ADCO)4.50 EGP
IBUFEN 2% SUSP. 60ML? strength differs? different route - not oral liquidALEXANDRIA4.50 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.